glaucoma and semaglutide may cause blindness—US study warning adds to growing debate on rare side effect Semaglutide Medications and Eye Health

Hims promises an easier start to online GLP-1 treatment

Subramanian and Rusch describe in a letter in Movement Disorders why weight loss in Parkinson's disease remains under-recognized and why monitoring nutrition should become a routine part of care

PlexusDx explains the physiologic mechanism and what clinical evidence reveals about cardiovascular safety

This review examines how Midi Health structures its provider assessment, genetic screening options, and medication access compared to precision-focused alternatives like PlexusDx

Amazon.com: GLP-1 Without The Hype: A no-nonsense guide to sorting facts, fear, side effects, and expectations (The Without the Hype Series): 9798243832656: Everheart, T.L., Busse, Teri: Books